Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Holly Huang"'
Autor:
Zhijun Zhang, Xinyu Ning, Jie Huang, Hongying Bao, Jie Chao, Jie Holly Huang, Chenggong Yu, Zhongjin Chen
Publikováno v:
ACS Applied Bio Materials. 3:2489-2498
Mesenchymal stem cells (MSCs) have shown potential as an innovative treatment for pulmonary fibrosis (PF), due to their capability to ameliorate the inflammation and moderate the deterioration of P...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::907f6364a29129322d2efc51848dd376
https://doi.org/10.1021/acsabm.0c00195
https://doi.org/10.1021/acsabm.0c00195
Autor:
Jie, Huang, Jie Holly, Huang, Hongying, Bao, Xinyu, Ning, Chenggong, Yu, Zhongjin, Chen, Jie, Chao, Zhijun, Zhang
Publikováno v:
ACS applied bio materials. 3(4)
Mesenchymal stem cells (MSCs) have shown potential as an innovative treatment for pulmonary fibrosis (PF), due to their capability to ameliorate the inflammation and moderate the deterioration of PF. The fate of the stem cells transplanted into the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7711edd1ea75dc3b62e99a51cbb4e6c2
https://pubmed.ncbi.nlm.nih.gov/35025299
https://pubmed.ncbi.nlm.nih.gov/35025299
Publikováno v:
Diabetes. 67
ITCA 650 consists of a small titanium osmotic mini-pump that is subdermally placed in the abdominal wall during a brief office procedure. As an investigational product for the treatment of type 2 diabetes (T2D), ITCA 650 provides a continuous subcuta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2fdcaefbf0e7b5e98e58861b91d3d9f
https://doi.org/10.2337/db18-1103-p
https://doi.org/10.2337/db18-1103-p
Publikováno v:
Diabetes. 67
ITCA 650 consists of a small titanium osmotic mini—pump that is subdermally placed in the abdominal wall during a brief in-office procedure. As an investigational product for the treatment of type 2 diabetes (T2D), ITCA 650 provides a continuous su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef4d9f9d5f966033205121adea53bb25
https://doi.org/10.2337/db18-1061-p
https://doi.org/10.2337/db18-1061-p
Autor:
Prakash Prabhakar, Neda Rasouli, Brian S. Schwartz, Samer Nakhle, Sydney L. Kruger, Michelle A. Baron, Julio Rosenstock, Holly Huang
Publikováno v:
Diabetes. 67
ITCA 650 is an investigational titanium osmotic mini pump that is subdermally placed in the abdominal wall during a brief office procedure to continuously deliver exenatide over 3 and 6-month periods and has the potential to improve medication adhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1008c2d44cce30acad183c89f3fd22ea
https://doi.org/10.2337/db18-1102-p
https://doi.org/10.2337/db18-1102-p
Autor:
Holly Huang
Publikováno v:
Journal of Biopharmaceutical Statistics. 30:216-217
This is the first edition of a comprehensive book covering the most recent methodology on innovative clinical trial designs for drugs and biological products. It is a great reference book for stati...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fab57a7b4bb06a3abd119885aac09ba
https://doi.org/10.1080/10543406.2020.1684183
https://doi.org/10.1080/10543406.2020.1684183
Autor:
Holly Huang, Dale Mohar, William E. Berger, Gordon Raphael, Joseph Hinkle, Craig LaForce, S.Y. Desai
Publikováno v:
American Journal of Rhinology & Allergy. 26:302-307
Background A new, hydrofluoroalkane nasal aerosol solution formulation of ciclesonide (CIC-HFA) delivered via a metered dose inhaler is currently in clinical development for treatment of allergic rhinitis. Objective To study tolerability and quality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97eb70fb0d9421d2498b885b055013e7
https://doi.org/10.2500/ajra.2012.26.3773
https://doi.org/10.2500/ajra.2012.26.3773
Publikováno v:
Sleep Medicine. 13:691-696
Background Insomnia marked by sleep maintenance difficulty is extremely prevalent. Yet, problems staying asleep have been relatively neglected as a research focus compared to problems falling asleep. Insomnia treatment studies typically have not requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ade59dd0f6bdfe9f0e806638ee613ff0
https://doi.org/10.1016/j.sleep.2012.01.010
https://doi.org/10.1016/j.sleep.2012.01.010
Autor:
Fred Bode, Bruce G. Martin, Paul H. Ratner, S.Y. Desai, Charles P. Andrews, William C. Howland, Joseph Hinkle, Holly Huang
Publikováno v:
Allergy and Asthma Proceedings. 33:27-35
A nasal aerosol formulation of ciclesonide with a hydrofluoroalkane propellant (CIC-HFA) is currently in development for treatment of allergic rhinitis (AR). This study evaluated the efficacy and safety of once-daily administration of CIC-HFA 74 or 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd5f3f1400e4520bca340a960b314a1
https://doi.org/10.2500/aap.2012.33.3490
https://doi.org/10.2500/aap.2012.33.3490
Autor:
Ruediger Nave, Mark A. Wingertzahn, Gary Maier, Paul H. Ratner, S.Y. Desai, Rolf Herzog, Holly Huang
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 24:426-433
Ciclesonide hydrofluoroalkane nasal aerosol (CIC-HFA) is currently in development for treatment of allergic rhinitis. This Phase I study evaluated the pharmacokinetics, pharmacodynamics, safety, and tolerability of CIC-HFA in healthy subjects (N = 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ab49a70beb4656eb091ceffe6f8d04
https://doi.org/10.1016/j.pupt.2011.04.002
https://doi.org/10.1016/j.pupt.2011.04.002